ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Nurse Practitioner

Top Nurse Practitioner Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LESLIE KENNEY NP

Nurse Practitioner

866

$35.6K

130
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $70

SANDRA ALFRED NP

Nurse Practitioner

833

$30.9K

188
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $70

BARBARA RAMPO FNP

Nurse Practitioner

775

$77.4K

142
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$100
Average prescription price

Avg: $70

JEANNE HOUTCHENS R.N.P.

Nurse Practitioner

732

$582K

82
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 22%

$795
Average prescription price

Avg: $70

SARAH CONGLETON NP

Nurse Practitioner

716

$46.1K

174
144 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $70

PETER REILLY NP

Nurse Practitioner

674

$49K

243
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $70

CAROL GARCIA-BENOIT RNP

Nurse Practitioner

662

$30.7K

147
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $70

JOHN DUFRESNE N.P.

Nurse Practitioner

608

$8,174

396
222 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$13
Average prescription price

Avg: $70

LARYL RILEY R.N.P.

Nurse Practitioner

600

$162K

156
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$271
Average prescription price

Avg: $70

ANNETTE FONTENEAU MSN, RNP

Nurse Practitioner

592

$38K

250
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $70

JEANNE KNIGHT NP

Nurse Practitioner

586

$25.6K

73
41 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $70

IRENE KOLBERG N.P.

Nurse Practitioner

566

$109K

157
128 are 65+

46%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$193
Average prescription price

Avg: $70

LAUREN CUSHING RNP

Nurse Practitioner

459

$49.4K

96
51 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$108
Average prescription price

Avg: $70

MARIANNE WOODRUFF RNP

Nurse Practitioner

376

$3,594

262
129 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 22%

$10
Average prescription price

Avg: $70

MARY ARTERY NP

Nurse Practitioner

364

$25.2K

106
64 are 65+

32%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $70

SARA WRISTON NPP

Nurse Practitioner

340

$155K

69
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$456
Average prescription price

Avg: $70

MAEVE DARGUSH N.P

Nurse Practitioner

339

$33.5K

49
30 are 65+

24%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $70

MARTHA FELDMANN NP

Nurse Practitioner

252

$47K

46
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 22%

$187
Average prescription price

Avg: $70

SUSAN BORDONARO R.N.P.

Nurse Practitioner

238

$43.5K

101
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$183
Average prescription price

Avg: $70

STEPHEN PROPATIER ACCNP

Nurse Practitioner

217

$5,538

96
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$26
Average prescription price

Avg: $70

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank